These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

128 related items for PubMed ID: 24843717

  • 1. Postprandial serum C-peptide value is the optimal index to identify patients with non-obese type 2 diabetes who require multiple daily insulin injection: Analysis of C-peptide values before and after short-term intensive insulin therapy.
    Fujiwara D, Takahashi K, Suzuki T, Shii M, Nakashima Y, Takekawa S, Yoshida A, Matsuoka T.
    J Diabetes Investig; 2013 Nov 27; 4(6):618-25. PubMed ID: 24843717
    [Abstract] [Full Text] [Related]

  • 2. A reliable serum C-peptide index for the selection of an insulin regimen to achieve good glycemic control in obese patients with type 2 diabetes: an analysis from a short-term study with intensive insulin therapy.
    Suzuki T, Takahashi K, Fujiwara D, Shii M, Takekawa S, Matsuoka T.
    Diabetol Int; 2016 Sep 27; 7(3):235-243. PubMed ID: 30603269
    [Abstract] [Full Text] [Related]

  • 3. Utility of indices using C-peptide levels for indication of insulin therapy to achieve good glycemic control in Japanese patients with type 2 diabetes.
    Funakoshi S, Fujimoto S, Hamasaki A, Fujiwara H, Fujita Y, Ikeda K, Takahara S, Nagashima K, Hosokawa M, Seino Y, Inagaki N.
    J Diabetes Investig; 2011 Aug 02; 2(4):297-303. PubMed ID: 24843502
    [Abstract] [Full Text] [Related]

  • 4. [Indicators for insulin therapy in late elderly patients with type 2 diabetes mellitus--the relationship between plasma C-peptide on glucagon load test and insulin therapy].
    Miyamoto M.
    Nihon Ronen Igakkai Zasshi; 2009 May 02; 46(3):244-9. PubMed ID: 19521045
    [Abstract] [Full Text] [Related]

  • 5. Increment of C-peptide after glucagon injection determines the progressive nature of Japanese type 2 diabetes: a long-term follow-up study.
    Fukui T, Oono K, Hara N, Yamamoto T, Nagashima M, Naito H, Hirano T.
    Endocr J; 2013 May 02; 60(6):715-24. PubMed ID: 23386398
    [Abstract] [Full Text] [Related]

  • 6. Short-term recovery of insulin secretion in response to a meal is associated with future glycemic control in type 2 diabetes patients.
    Enkaku A, Chujo D, Kamigishi M, Inagawa S, Matsukoshi S, Sakai W, Takikawa A, Fujisaka S, Tobe K.
    J Diabetes Investig; 2024 Apr 02; 15(4):437-448. PubMed ID: 38151917
    [Abstract] [Full Text] [Related]

  • 7. Correlation of serum CPR to plasma glucose ratio with various indices of insulin secretion and diseases duration in type 2 diabetes.
    Okuno Y, Sakaguchi K, Komada H, Hashimoto N, Hirota Y, Nakamura T, Ogawa W, Seino S.
    Kobe J Med Sci; 2013 Apr 18; 59(2):E44-53. PubMed ID: 23756662
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Basal insulin ameliorates post-breakfast hyperglycemia via suppression of post-breakfast proinsulin/C-peptide ratio and fasting serum free fatty acid levels in patients with type 2 diabetes.
    Ogiso K, Koriyama N, Obo T, Tokito A, Nishio Y.
    Diabetol Int; 2021 Apr 18; 12(2):161-170. PubMed ID: 33786271
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Postprandial serum C-peptide to plasma glucose ratio as a predictor of subsequent insulin treatment in patients with type 2 diabetes.
    Saisho Y, Kou K, Tanaka K, Abe T, Kurosawa H, Shimada A, Meguro S, Kawai T, Itoh H.
    Endocr J; 2011 Apr 18; 58(4):315-22. PubMed ID: 21415555
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Effects of short-term intensive glycemic control on insulin, glucagon, and glucagon-like peptide-1 secretion in patients with Type 2 diabetes.
    Shimodaira M, Muroya Y, Kumagai N, Tsuzawa K, Honda K.
    J Endocrinol Invest; 2013 Oct 18; 36(9):734-8. PubMed ID: 23580083
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Analysis of factors influencing pancreatic beta-cell function in Japanese patients with type 2 diabetes: association with body mass index and duration of diabetic exposure.
    Funakoshi S, Fujimoto S, Hamasaki A, Fujiwara H, Fujita Y, Ikeda K, Hamamoto Y, Hosokawa M, Seino Y, Inagaki N.
    Diabetes Res Clin Pract; 2008 Dec 18; 82(3):353-8. PubMed ID: 18950889
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Utility of glucagon stimulation test in type 1 diabetes after pancreas transplantation.
    Hiratsuka I, Suzuki A, Kondo-Ando M, Hirai H, Maeda Y, Sekiguchi-Ueda S, Shibata M, Takayanagi T, Makino M, Fukami N, Itoh T, Sasaki H, Kusaka M, Kenmochi T, Hoshinaga K, Itoh M.
    Transplant Proc; 2014 Apr 18; 46(3):967-9. PubMed ID: 24767392
    [Abstract] [Full Text] [Related]

  • 19. [The effects of early intensive therapy on islet beta cell function and long-term glycemia control in newly diagnosed type 2 diabetic patients with different fasting plasma glucose levels.].
    Li YB, Zeng LY, Shi LX, Zhu DL, Zhou ZG, Yan L, Tian HM, Luo ZJ, Yang LY, Liu J, Weng JP.
    Zhonghua Nei Ke Za Zhi; 2010 Jan 18; 49(1):9-13. PubMed ID: 20356473
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.